Debate about funding comparative-effectiveness research
N Engl J Med
.
2009 May 7;360(19):1927-9.
doi: 10.1056/NEJMp0902427.
Author
Jerry Avorn
1
Affiliation
1
Harvard Medical School, and Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, USA.
PMID:
19420361
DOI:
10.1056/NEJMp0902427
No abstract available
MeSH terms
Cost-Benefit Analysis
Dissent and Disputes
Financing, Government / legislation & jurisprudence*
Health Services Research / economics
Health Services Research / legislation & jurisprudence*
Politics
United States